← Eichor
Study identifier: NCT07324694 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Impact of Intraoperative Hemodynamic Instability on Outcomes in Cardiac Surgery

Condition: Cardiac Surgery · Intraoperative Hemodynamic Instability · Postoperative Complication  ·  Sponsor: Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital

PhaseN/A
Planned participants230
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Intraoperative hemodynamic instability (IOHI) is a common occurrence during cardiac surgery and is associated with organ hypoperfusion. However, the specific impact of IOHI on composite adverse outcomes remains unclear. This prospective cohort study aims to evaluate the association between intraoperative hemodynamic instability (defined as MAP \< 65 mmHg or vasopressor requirement) and major postoperative complications (Delirium, Acute Kidney Injury, Stroke, or Mortality) in adult patients undergoing elective cardiac surgery with cardiopulmonary bypass.

This description comes directly from the study's public registry record.

Talk to the study team

Osman Uzundere, M.D.  ·  +905330206362  ·  osmanuzundere@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Gazi Yaşargil Training and Research HospitalDiyarbakır, Diyarbakır, Turkey (Türkiye)Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07324694